Functional annotation and enrichment analysis of differentially expressed serum proteins in patients with type 2 diabetes after dapagliflozin

BACKGROUND: Only 50% of patients with type 2 diabetes mellitus (T2DM) can control their blood glucose levels. Dapagliflozin is a selective inhibitor of sodium-glucose co-transporter 2 (SGLT-2) that improves the insulin sensitivity of the liver and peripheral tissues. Many studies confirmed that SGLT...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Yan-Xue, Borjigin, Sarul, Yan, Zhao-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2022
Materias:
Case Control Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984562/
https://www.ncbi.nlm.nih.gov/pubmed/35432754
http://dx.doi.org/10.4239/wjd.v13.i3.224

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8984562/
https://www.ncbi.nlm.nih.gov/pubmed/35432754
http://dx.doi.org/10.4239/wjd.v13.i3.224

Ejemplares similares